Repligen (RGEN)
(Delayed Data from NSDQ)
$116.50 USD
-2.41 (-2.03%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $116.50 0.00 (0.00%) 4:42 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2025
Time: -- |
9/2025 | $0.42 | 1.23% |
Earnings Summary
For their last quarter, Repligen (RGEN) reported earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.40 per share. This reflects a negative earnings surprise of 7.50%. Look out for RGEN's next earnings release expected on November 11, 2025. For the next earning release, we expect the company to report earnings of $0.42 per share, reflecting a year-over-year decrease of 2.33%.
Earnings History
Price & Consensus
Zacks News for RGEN
Here's Why Repligen (RGEN) is a Strong Growth Stock
RGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?
Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report?
QGEN or RGEN: Which Is the Better Value Stock Right Now?
RGEN FAQs
Repligen Corporation (RGEN) has announced they will report their next quarter earnings on November 11, 2025. For the next earning release, we expect the company to report earnings of $0.42 per share, reflecting a year-over-year decrease of -2.33%.
Repligen Corporation has announced they will report their previous quarter earnings after the close of the market on November 11, 2025.
The Zacks Consensus Estimate for Repligen Corporation (RGEN) for the quarter ending in September 2025 is $0.42 a share. We expect Repligen Corporation to miss by 1.23%.
In the earnings report for the quarter ending in June 2024, Repligen Corporation (RGEN) announced earnings of $0.33 per share versus the Zacks Consensus Estimate of $0.33 per share, representing a surprise of 0.00%.